US stock · Healthcare sector · Drug Manufacturers—General
Company Logo

Merck & Co., Inc.

MRKNYSE

93.55

USD
+1.46
(+1.59%)
Market Closed
16.74P/E
13Forward P/E
0.65P/E to S&P500
236.570BMarket CAP
2.87%Div Yield
Google Trends
Recent Reddit Comments

Sector wise, I believe big Pharma(ABBV, LLY, AZN, GSK, MRK) will hold their value and minimize losses. My TDA picks.

On Hood I play a mixed bag, FCX, AMD, LCID, VALE, RBLX, BNTX and CDE. It worked out today(05.19) but not always. Lost some yesterday(05.17) on those.

1
Reply
Share
Report
Save
Follow

TTM Return: +5.85%. That's the whole portfolio though. Most of the stocks I've bought recently are down, except Merck ($MRK). Merck is kicking ass.

1
Reply
Share
Report
Save
Follow

MRK

1
Reply
Share
Report
Save
Follow

Buffett’s 13D: started positions in RND & RPRX. Sold out MRK.

1
Reply
Share
Report
Save
Follow

If you all want a ticker that just fucking gears check out MRK. I tried to short that fucker so many times

1
Reply
Share
Report
Save
Follow

It does seem like that recently. I'll admit, I did often advocate for people to just invest into ETFs, but that was for the instances where they didn't seem to know what they were doing yet and/or were balls deep in highly speculative cash burning meme stocks, some of which were already on their way to bancruptcy.

I'd really enjoy it if we got more quality posts, people sharing their DD on certain companies or really just looking to discuss them, and those posts not always being about the same 10 companies over and over again.

Like when's the last time anyone on here discussed MCO? I recently tried to get into some sort of dialogue about it in the daily stocks discussion and didn't even get so much as an answer.

Or DAL or MRK or fuck I know, fucking K for all I care? Just stocks that may be out of the field of vision of others, or some that have stood when looking into them, maybe just some you have a particular understanding or interest for.

And even some of the tickers that have come up more often recently like SONY, F or CRM haven't really been discussed at all.

Or how I'd love to see some discussion about VOW3.DE on here - although I wouldn't expect that since it's very US-centric here.

1
Reply
Share
Report
Save
Follow

"What the fuck are these retarded nerds talking about? Market crash? What market crash?"

-COP, MRK, KO shareholder

1
Reply
Share
Report
Save
Follow

I dd MRK Cash flow Low debt

1
Reply
Share
Report
Save
Follow

I feel like MRK is solid as a company and has great dividends

1
Reply
Share
Report
Save
Follow

Where is the value in a dollar bill? A bar of gold? An abstract painting?

Value isn't an intrinsic feature of an object, it is a feature we give objects through our attention. Much of humanity agreed that gold could be mined reliably enough to use as a currency, so it was. A few events in history expedited the process (looking at you, Mansa Musa). The world was going to end when the gold standard was left. And... it didn't.

Gold has not held up this time the same as in previous bouts of inflation. In general both it and silver have taken a non-stop beating for a few years now. A lot more people are asking the same thing you do of bitcoin, but about gold. I think the bitcoin is gold 2.0 thing might have fueled that. Gold, or bitcoin, or yen, or dollars are all worthless. There is no specific state of nature they lay dormant in, to suddenly reveal their value when a species became smart and strong enough to rip it from the ground.

Bitcoin won't be the next primary currency though. Every government has a reason to stifle it, stop it or embrace it and that's already creating a hodgepodge of nonsensical laws around the globe. However, whatever the next currency is it will more resemble bitcoin than the dollar, certainly more than a gold bar.

So screw gold. Screw bitcoin. Buy MRK; GILD; MATX; RIO; BMO!

Instead.

1
Reply
Share
Report
Save
Follow

My position is all over the place. I have TSLA, IGOV, PSEC, RMCF, MJ (what a loser this stock is), NBEV, LUV, ELY, MNRL, FCX, TRX, SLV, RIOT, COIN, PII, AIV, HNST, HOOD, JOAN, VZ, VZIO, RGR, VSTO, ASTS, OLN, CFVI, MRK, INVZ, GRAB, MNMD, VLD, BKE, TWTR. I’m holding in pain.

1
Reply
Share
Report
Save
Follow

I’ve made 14 percent on Kellogg this year. Swung traded WHR and JNJ for 10 percent gains. Idk…..not 1000 Long term gains but a lot for holding something for a few weeks. That’s my way. Not betting on tech bubbles or big pharma. I’m not criticizing your approach I’m just shedding light. I used to own MRK and Pfizer and then sat down and actually read about them and think the animal testing and using animal parts as well as injuries from medication were just too much for me. I mean, people can say big banks are unethical and all but no one was ever left maimed from a big bank. At most they lost a house they knew they couldn’t afford buying when they bought it. The moral trade off leaned me more heavily into financials, if I had to pick

1
Reply
Share
Report
Save
Follow

AVGO, QCOM, TXN, ABBV, PFE, MRK, ABT are a few good picks for the sectors you mentioned. As for other sectors, I’m currently looking at LOW, UPS, RIO, BHP, CE, RS, and a few others

1
Reply
Share
Report
Save
Follow

try VTIP for 2-3% interest. For some time, there has been Canadian $-mrk etf that pays 14.5% interest. It consists of 15 top Canadian banks. But State Dept put that CD on banned list possibly doing business with China.

1
Reply
Share
Report
Save
Follow

The following stocks are only 4% from their peak. Weathered this correction strongly!

VLO -3.95% KO -3.85% BMY -3.71% XEL -3.67% WM -3.37% JNJ -3.34% PEP -3.33% MRK -2.96% PG -2.90% MO -2.59% HSY -2.52% K -2.44% CERN -0.36%

The following stocks are down over 50% from their peak. Clobbered!

MRNA -72.98% NFLX -72.84% PYPL -71.65% ETSY -69.72% GPS -66.99% PENN -61.69% ALGN -60.69% IPGP -59.37% GNRC -58.16% CDAY -56.95% MTCH -56.51% BIIB -55.73%

1
Reply
Share
Report
Save
Follow

Opened a few new positions today to take advantage of current share prices.

From the one I am most confident about to the least, they are MRK; GILD; BLK; BEN; MAXR

GILD and BEN have particularly attractive dividends, and BEN is a Dividend Aristocrat.

1
Reply
Share
Report
Save
Follow

I reiterate that I have had MRK for awhile and new upgraded ratings, only single thing stayed green throughout everything. 35% return overall and dividends are nice. MRK

1
Reply
Share
Report
Save
Follow

Some are saying we're in a 'stock picker's market' after a few years in a bull run that caused most stocks to continually rise. I think there's a lot of truth in this; inflation, the war in Ukraine, covid lockdowns in China, supply chain bottlenecks are all causing stocks to swing wildly and out of sync with each other. If this is a recession (I remain unconvinced) then that is merely another reason why it is more important to pay attention to the actual business and financials underlying any stock you invest in.

I've made money in the past few months - as the war in Ukraine began to look inevitable I moved heavily out of tech. ABBV; MRK; ZIM; MATX; ADM all have done really well. ETFs like AMLP; MOO; XLP; VTV all have done well. Pharmaceuticals seem to have largely valued at this point, though - but shipping stocks are extremely volatile and recently plunged (good time to buy). Agribusiness is going to benefit from the horrid food situation arising from the Russian war in Ukraine.

There are companies that are truly solid, who are in it for the long haul, have long-term plans and are prepared for economic turbulence. Some - namely those in consumer staples, utilities, energy and some healthcare & industrials - will thrive in a recession, because it is a recession. Others will bounce back quickly - and many will be a shadow of their former selves.

1
Reply
Share
Report
Save
Follow

>Earnings $CAT $MRK $LLY $CARR https://t.co/AHy2YbxpdB

^*Walter ^Bloomberg ^@DeItaone ^at ^2022-04-28 ^06:40:06 ^EDT-0400

1
Reply
Share
Report
Save
Follow

MRK $86/c for tomorrow! 🚀🌙

1
Reply
Share
Report
Save
Follow

I'm down about 4%... don't really feel bad at all... MSFT is my biggest hit. Covered that with MRK and BCBP (don't ask why). And my largest single holding is VTV (large cap value), which didn't take too much of a hit.

My 401k is in a vanguard target date fund, which took a beating, but I only started contributing last year so in real terms it's not so bad.

1
Reply
Share
Report
Save
Follow

All the boomer stuff (LMT/BAC/AXP/ITA/XLU/SHEL/ERF/SCCO/JNJ/MRK) I've bought LAST YEAR are doing pretty well. Most of the puts I've sold turned out ok well. Even my TWTR from before is gonna get bought at $54.20^(blaz it).

I've been pretty thirsty and trying to resist buying the dip on TECH. A lot of momentum retards on WSB are now memeing about how we should buy gold/oil/uranium/boomerstocks NOW at ATH (just like how they were shilling tech stocks last year), but then they wonder why they always lose money.

1
Reply
Share
Report
Save
Follow

MRK?

1
Reply
Share
Report
Save
Follow

medical stuff (TMO, MRK, LLY, DHR, AMGN) clearing space for the next run higher imo.

1
Reply
Share
Report
Save
Follow

I’m an ABBV & MRK shareholderimg

1
Reply
Share
Report
Save
Follow

ABBV, MRK, COST. I will HOLD.

1
Reply
Share
Report
Save
Follow

ABBV, MRK

1
Reply
Share
Report
Save
Follow

MRK

1
Reply
Share
Report
Save
Follow

Ok I made $57 today so let me tell you idiots something. Buy MRK. I'm a chicken shit so I traded against myself earlier in the week but this thing is going somewhere between $90-$95 soon and the calls are cheap. Lot of momentum and it isn't even a shit company. I'd be up like 60% if I could keep my conviction on a down day.

Only shit part is this thing goes up way more when rest of market is down. It goes up on green days too but with less gusto.

1
Reply
Share
Report
Save
Follow

My single stonk that stayed green the whole time is…drumroll…Merck #MRK (WTH?)

1
Reply
Share
Report
Save
Follow

I am; I have a portfolio made almost entirely on blue-chip dividend growth stocks, spread across ~34 positions in 6-7 sectors. Currently up about 3% in the past 3 months, 12% in the past 6 months. Beating all 3 indexes.

Positions are: $A, $AAPL, $ABBV, $AFL, $ALL, $AVGO, $CLX, $CVX, $ENB, $EPD, $FLO, $HII, $JNJ, $KMB, $KO, $KR, $LMT, $LOW, $MAIN, $MDT, $MO, $MRK, $MS, $MSFT, $O, $OKE, $PEP, $PFE, $PG, $STAG, $T, $TGT, $TROW, and $XOM

1
Reply
Share
Report
Save
Follow

MRK, JNJ, ABBV, ABT are great starting places. AMGN, CI, UNH all good healthcare companies consistently increasing dividends. There are a bunch, but these tend to be popular.

1
Reply
Share
Report
Save
Follow

Started investing Mid-February. Obviously I could have made some better positions but here is my portfolio so far:

Index:

VTI - 21.98%

SMH - 5.21%

VHT - 4.91%

XAR - 4.81%

XLF - 4.44%

Stock:

MSFT - 11.91%

COST - 11.12%

LMT - 8.52%

AAPL - 6.74%

AMD - 6.33%

MRK - 4.75%

ABT - 4.57%

VWAPY - 3.31%

F - 1.31%

1
Reply
Share
Report
Save
Follow

NEE
COST
CVX
LRCX
LMT
JPM

CHD

CSX

AMZN
WMT
MCD
DHI

UNH

JNJ
MRK

MA
MSFT

1
Reply
Share
Report
Save
Follow

BRK.B MRK MMM

1
Reply
Share
Report
Save
Follow

Berkshire's good. Then MSFT and a large-cap pharma like MRK or PFE. I personally prefer Merck right now as a long-term own

1
Reply
Share
Report
Save
Follow

REFERENCE #4: LOL, I just completely responded to your comments and lost it all as I wanted to copy a reference to the best explanation for the Wheel Strategy I've stumbled upon after reading Scot's in the OptionsWheel community months ago: "The Options Wheel Strategy", by Freeman Publications May 19, 2021, available on Amazon. This booklet costs about $10 or less, and it fully describes Scot's and "my" approach.

MONTHLIES/WEEKLIES: Some have said that the cumulative premium from weeklies is a few percentage more than monthlies, but the difference can be totally skewed by all the factors in the option pricing model, especially by VOL, market sentiment, etc. My thinking is to keep it simple and "mechanical": Sell premium each week about 42-49 days out on Fridays or whenever, and roll every 21 DTE Friday or Monday or so, back out to 42-49. In between you decide to get in and out of the stock for maximum credits (generally Scot's approach, shorter term) or milk the CSPs and CCs as long as possible so that you can also possibly capture dividends and capital gains (generally my approach, longer term).

WHEEL STRATEGY: If a good stock or ETF meets your Trading Plan objectives, they are candidates. IMO, the number one item on that checklist on trade entry is liquidity: I scan for a minimum of 1MM shares daily over a 10 bar period. ThenI look at the bid/ask in a number of DTEs in the Option chain to see if they are close or far apart, especially in the 21-49 day cycles. Then look at the credit available in the 30-40 delta range CSP/CC sides to see if it is economically worthwhile for your risk/buying power...I try to get about 2% of the stock price each side. I generally don't care what VOL is as the historical 12-month IV risk is captured by the expected move for each cycle, but I do check the IVRank and IVPercentile to inform my decision. If you use TOS, u/mobius provided a great IVR script for your charts that posts this info on each chart.

BACKTESTING: I'm not a fan of backtesting, as all it proves IMO is what happened at some period in the past...COVID, UKRAINE, FED, TWEETS, other numerous influences, etc...market sentiment at any given time completely changes these results. Keep it simple and base your decisions on solid facts and performance of your target underlyings. LOL, I do own KO and MRK, just because they hit my scan at the time. TOS provides more than enough free backtesting, company data, scan capabilities, etc...just open an account...I don't think they require funding if you do to use their TOS platform.

1
Reply
Share
Report
Save
Follow

First of all, thank you so much!

Regarding 2.: Adding up the premiums of the fridays equals the premium of the monthly contract, if im right. What are the advantages of choosing the weeklies? Elevated gamma risk in this case is not relevant, I guess.

Regarding 4.: I would love to do XLP, but it is quite illiquid option-wise. The value stock approach leeds us to a kind of Buffett investment space: KO and JNJ are my best guesses, or do you favor more neutral outlooks for the wheel like MRK?

1
Reply
Share
Report
Save
Follow

I was thinking of buying MRK all in shares

1
Reply
Share
Report
Save
Follow

$SCHD. Yeah it's a dividend ETF but here are the top 10 holdings that make up 40% of the fund. Dividend stocks have less volatility generally than other stocks and perform better in a recession. It's pretty diversified.

Merck & Co Inc MRK 4.24%

The Home Depot Inc HD 4.19%

Texas Instruments Inc TXN 4.16%

Broadcom Inc AVGO 4.15%

Amgen Inc AMGN 4.11%

PepsiCo Inc PEP 4.09%

BlackRock Inc BLK 4.05%

Pfizer Inc PFE 3.97%

Cisco Systems Inc CSCO 3.96%

Verizon Communications Inc VZ 3.96%

1
Reply
Share
Report
Save
Follow

“For what shall it profit a man, if he shall gain the whole world, and lose his own soul?” ‭‭Mark‬ ‭8:36‬ ‭KJV‬‬ https://bible.com/bible/1/mrk.8.36.KJV

1
Reply
Share
Report
Save
Follow

It’s been 11 years, so bear with me. Details are a bit fuzzy, we were an institutional account, and things may have changed since them. However, I have experience here.

In 2011, my hedge fund was long a ton of Chinese fraud puts. The very first put that was halted before delisting was CCME. We had March $11 puts. We were short shares. Because they were halted, you could not transact shares on an exhchange and clear them.

The shres were listed on NASDAQ. They were halted on NASDAQ. The options were CME, and the options did not trade, but they could in fact be exercised manually if you wanted to. We had a menu of puts from like $9 down to $4. The stock was halted at $11.50 or something. We thought it was a zero. Here is the process when you mnaully exercise options:

1). You manually exercise the puts with the CME via your custodian. This will mnually need to be entered. Ypur mrk to market will be highly negative if the last trade is out of the money.

2). You cannot get shares, so you fail to deliver. This shows up on the daily report of failure to delivers.

3). You do NOT pay borrow fees because you do not have the shares borrowed. In fact, we had to pay borrow fees at last trade and annual rates on our shorted shares, and the stock didn’t open for like 6 months and it obviously had an inflated last price.

4). You can’t be bought in because nobody can get the shares. It’s just going to fail in DTC until you can deliver. Given this special circumstance, I have no idea how you will ever deliver. You may perpetually owe money on a $0.01 value or maybe they can close the ccount? This is the one area I did not deal with as CCME and all our other frauds re opened. You can call the holders of the ETF or shares and see if they will do a “penny for the lot” transaction privately to get the shares to your account.

5). The day it opens your custodian can threaten to buy you in on the open, but ideally you have some time to buy and deliver that day as you please.

Shares are bought and delivered, option position is closed out. All is over.

1
Reply
Share
Report
Save
Follow

Got a nice list of stonks: PEP, BMY, AVGO, CVS, MRK, PG, HD. They all pay a dividend.img

1
Reply
Share
Report
Save
Follow

I have learned a lot in my less than year of experience trading/investing. I’ve lost money. All because I was emotional. If your purchases are backed up by companies research and companies you like, long term will beat out short term. If something is attractive at X price, then it’s even more attractive when it’s lower. I thought JPM was awesome at $140 so I bought. Now it’s down to $133 so I’m buying here and there. Same with MS, MRK & FFIN. Good companies will recover. Focus on a few really solid companies and then buy when you can

1
Reply
Share
Report
Save
Follow

For every day that my portfolio closes red, I do 20 pull-ups and 50 push-ups. And I have been overweight on MRK and biotechs for the past year. Need I say more?

1
Reply
Share
Report
Save
Follow

Here is my list presented in order of under to over priced in my opinion. Spoiler - You'll be sad when they get called away if you buy the undervalued ones.

​

ENB

MO

WU

BTI

GILD

ABBV

IBM

PM

UNM

XOM

VTRS

AMGN

LEG

BEN

UGI

MMM

xle

WBA

Ul

EFA

MRK

T

jpm

BMO

PFE

KHC

VZ

CLX

KMB

HD

DUK

SO

PEP

SJM

SBUX

ITW

OZK

INTC

xlp

CAH

BMY

K

MET

KO

ED

MDT

TROW

MDLZ

csco

IVZ

LMT

xlre

BAC

xlu

AOS

cpb

HRL

xlf

CAT

MCD

D

JNJ

APD

HON

PBCT

NEE

CMCSA

LHX

RHHBY

BLK

PG

CL

MDT

xlb

GPC

GD

xlv

ATO

SYY

ROST

UPS

cinf

SHW

ADM

lin

RTX

SWK

xli

SPY

hsy

EMR

LOW

MKC

ABT

WM

CB

DIS

xlk

BDX

NKE

WMT

PPG

LRLCY

CHD

EXPD

TGT

xlc

WFC

ALB

SPGI

xly

AAPL

BRO

ROP

WST

1
Reply
Share
Report
Save
Follow

Got a long one for y’all but any input is appreciated. 23 years old full time in finance for 10 months now, still living at home and invest roughly 75-80% of my paycheck each month:

Taxable: $BA $DAL $FB (yeah Ik sigh) $JPM $KULR $LOW $LUV $MRK $MSFT $MVIS $SOFI $V $$Each of the 11 Sector ETFs$$

RIRA: $BABA (sigh) $CWH $FB $HEAR $HOG $KULR $MVIS $TGT $NVDA $$Each of the 11 Sector ETFs$$

1
Reply
Share
Report
Save
Follow

Irm, abbv lmt, wpc, ibm, bti, enb, msft, appl, Mpw, mrk. That’s my 10

1
Reply
Share
Report
Save
Follow

Account opened down 20% this morning, ended the day up 3% thanks to MRK and VALE calls. Hope yall did better than I did today.

1
Reply
Share
Report
Save
Follow

Damn bruh MRK FDs 10 baggers shoulda bought more

1
Reply
Share
Report
Save
Follow

Just a reminder, I mentioned the 20k buy on $85 calls on MRK this morning they're already up 100%

1
Reply
Share
Report
Save
Follow

MRK calls printing since open. Yeaaaaa

1
Reply
Share
Report
Save
Follow

> 20000 3/18 $85 call buy order on MRK

Nancy is that you?

2
Reply
Share
Report
Save
Follow

Anyone else notice that 20000 3/18 $85 call buy order on MRK yesterday for around .06 a contract? That was at ask.

1
Reply
Share
Report
Save
Follow

First time ever as I can remember market goes down and my stocks do not. I do two strategies:

  1. Carry Strategy (dividend stocks): YTD -0.8%. Contains ABBV,AVGO,CAT,CLX,CMI,CSCO,CTVA,DD,DOW,EMR,F,FE,GILD,GIS,HST,IBM,IFF,JNJ,K,KD,KMB,LMT,LUMN,MET,MRK,NUE,O,OGN,ONL,OXY,PFE,PFG,PM,PRU,SLB,T,TRI,VTRS,VZ
  2. Momentum and growth, my playground: YTD +3.13%. Contains AA,AEG,ANDE,AR,ARCB,ARCH,BBAR,BG,BIG,BP,CEIX,CENX,CEPU,CLS,CMC,COWN,DAR,E,HBM,HIMX,HUN,KMX,LPI,MLI,MT,MUSA,PTR,SHEL,RUSHA,SM,SMCI,TBI,TMST,TPH,TROX,TRQ,UVE,VIST,VTOL,WFG,ZIM

Almost no tech, some energy, all sectors. 80 titles, shit, that is a lot. I don't like to sell, my motto: hold as long as possible... but not longer.

BTW: I explained my carry strategy rules here: I am a robot

6
Reply
Share
Report
Save
Follow

ARKG has some questionable picks, but the beatdown doesn't have that much to do with ARKG itself necessarily, the entire sector's valuations got ahead of themselves, especially the ones ARK sought out it seems

Now, though, they've been beaten down so much and so far that there are some great finds to be had for cheap. I came across survey saying that biotech valuations haven't been this depressed in a long time relative to the broader market's, and they haven't been this oversold in a while

I try to buy revenue generating companies and these are on my buy list. All are innovative and financially healthy in proteomics, rare diseases and autoimmune conditions, RNAi therapeutics, diagnostics: HZNP, QTRX, FLGT, ARWR. CMPS my highly speculative pick

DRNA I had but it got bought out, showing promise in RNAi work

In general, I think one of two things can happen for biotech investor: their company either gets bought out, or it gets large enough that it starts to buy out others. You want to be in those companies, not the thousands (yes, thousands) that languish on the indices despite all the hype

Others are in biosimilars and are big pharma types and I think may do quite well just printing money as value stocks now: MRK, VTRS, OGN, SUPN, TAK, GRFS

Very hard to find the biotech companies with good, marketable, and actually lucrative science and hold on to the extremely volatile stocks of these companies. So I understand the appeal of ARKG

That said, I'm a fan of FHLC, a Fidelity ETF that has both the big pharma companies and little bits of the more speculative and highly speculative companies. Performance not half bad, and the holdings are a good place to start if you want to do research on good companies

1
Reply
Share
Report
Save
Follow

ARKG has some questionable picks, but the beatdown doesn't have that much to do with ARKG necessarily, the entire sector's valuations got ahead of themselves

Now, though, they've been beaten down so much and so far that there are some great finds to be had for cheap. I came across survey saying that biotech valuations haven't been this depressed in a long time relative to the broader market's, and they haven't been this oversold in a while

I try to buy revenue generating companies and these are on my buy list. All are innovative and financially healthy in proteomics, rare diseases and autoimmune conditions, RNAi therapeutics, diagnostics: HZNP, QTRX, FLGT, ARWR

DRNA I had but it got bought out, showing promise in RNAi work

In general, I think one of two things can happen for biotech investor: their company either gets bought out, or it gets large enough that it starts to buy out others. You want to be in those companies, not the thousands (yes, thousands) that languish on the indices despite all the hype

Others are in biosimilars and are big pharma types and I think may do quite well just printing money as value stocks now: MRK, VTRS, OGN, SUPN, TAK

Very hard to find the biotech companies with good, marketable, and actually lucrative science and hold on to the extremely volatile stocks of these companies. So I understand the appeal of ARKG

That said, I'm a fan of FHLC, a Fidelity ETF that has both the big pharma companies and little bits of the more speculative and highly speculative companies. Performance not half bad, and the holdings are a good place to start if you want to do research on good companies

1
Reply
Share
Report
Save
Follow

Putin is not invading his mob bosses would mrk him so fast for fucking up their money

1
Reply
Share
Report
Save
Follow

any news come out about GSK or MRK? Checked their charts and seems they both had dips right at bell

GSK has a competitor for the shingles vaccine but that was all I read about "bad" news (which isn't even bad)

3
Reply
Share
Report
Save
Follow

>Do you think Pfizer is undervalued right now due to incorrect interpretation of future vaccine and anti-viral drug sale projections?

I believe Pfizer is trading at a very slight premium due to an incorrect interpretation from the market of COVID related sales going into late 2022 and, more importantly, 2023-2025. I expect such a revenue to actually taper off, not grow, sharply.

>More a more general level, do you think Pfizer is going to wisely invest its covid windfall and develop great revenue streams?

I think Pfizer already has invested some of the COVID related profits wisely, though they remain behind the industry average for R&D investments if I'm remembering right. Pfizer sports 89 products on their pipeline, ten of which in the process of being registered (5 COVID related).

>Do you consider Pfizer a great buy or not? Is this a long term hold? The pe ratio is 13. Is that considered normal for drug companies?

  1. I think, despite saying earlier it's trading at a premium, it's still a decent investment. I'd wait before pulling the trigger though.
  2. Yes, Pfzier is a long term hold. Aside from sporting a healthy dividend TTM 3.04% yield (39.69% payout ratio), which is already attractive to me, Pfizer has a substantial stable moat in the Healthcare space. A diversified product catalogue and no patents expiring till 2028 (Eliquis comes to mind) alongside a strong distribution network all help to keep it's pricing power for drugs in the company's favor.
  3. Pfizer's p/e ratio of 15.83 (where did you get 13?) is fairly competitive with other companies in the industry. Similar to other companies like $NVS and $MRK that I'd recommend to others for due diligence research.
2
Reply
Share
Report
Save
Follow

Anyone looking at astrazenika puts for earnings? If CPI hits could be a double whammy for an earnings miss. Phizer and mrk both reacted poorly

1
Reply
Share
Report
Save
Follow

Added some MRK, KHC, PFE, and BABA today (and no, I didn't get the 5% bump on BABA...)

1
Reply
Share
Report
Save
Follow

ROTH IRA - VOO, VTI, VFH, VDE, VIG, VDC NVDA, MRK, APPL, COST, DIS, and ABBV.

1
Reply
Share
Report
Save
Follow

25M by and large going for long term gains. New to the stock market as of summer 2020.

AAPL 26% NVDA 22% LOW 14% BRK-B 9% PLUG 8% MRK 7% CRM 7% F 3% VZ 2% SPCE 1%

1
Reply
Share
Report
Save
Follow

I dunno if I’d say “ dump “ but I’ve definitely been rotating more into tech with these dips. I was heavy in big pharma before ( GSK, MRK, etc.) as well as BTI, LMT. I sold a nice chunk of my positions and moved into AMZN at 2700, CRM at 225, and just today FB at 240$. I feel these are starting to get a bit too undervalued and wanna diversify a bit more into tech, so I used my sold positions above and bought into these guys! Non tech stocks I like are K and BUD here too. TROW as well.

1
Reply
Share
Report
Save
Follow

mrk, hon, ea, ms

yep

1
Reply
Share
Report
Save
Follow

mrk very close to intraday buy range. a little earlier than my 1pm target, but near the 79.00 level that interests me.

1
Reply
Share
Report
Save
Follow

MRK approaching my rebuy area. low 79s, perhaps 79.07 would be good.

also could fall all day, be careful.

very positive guidance however...

0
Reply
Share
Report
Save
Follow

MRK looking like a low around 130 pm EST, 79.14

prediction

1
Reply
Share
Report
Save
Follow

flipped mrk again

1
Reply
Share
Report
Save
Follow

flipped MRK, will rebuy back in near 80, into 79.50s

1
Reply
Share
Report
Save
Follow

I'll be attacking MRK I think, good quarter & guidance

1
Reply
Share
Report
Save
Follow

Need a MRK rally today. Very good earnings report. Time to gap up!

1
Reply
Share
Report
Save
Follow

>*MERCK & CO SEES 2022 ADJ EPS $7.12 TO $7.27, EST. $7.28 $MRK

^*Walter ^Bloomberg ^@DeItaone ^at ^2022-02-03 ^06:32:26 ^EST-0500

1
Reply
Share
Report
Save
Follow

MRK do not be like FB or SPOT.

1
Reply
Share
Report
Save
Follow

MRK

1
Reply
Share
Report
Save
Follow

MRK better pump in the morning! ATH would be nice.

1
Reply
Share
Report
Save
Follow

Mrk calls. Something something pharmaceutical shit

1
Reply
Share
Report
Save
Follow

#Calls on MRK CHECK!!!

1
Reply
Share
Report
Save
Follow

Anyone thinking of playing MRK?

1
Reply
Share
Report
Save
Follow

All across healthcare spectrum: ABT CI HZNP QTRX FLGT TAK MRK

1
Reply
Share
Report
Save
Follow

I WAS RIGHT ABOUT XOM 🚀🚀🚀 NEXT IS MERCK(MRK)

1
Reply
Share
Report
Save
Follow

#ALL IN ON MERCK(MRK)🚀🚀🚀🚀🚀🚀

1
Reply
Share
Report
Save
Follow

EARNINGS CALLS ON. EXXON(XOM) TUESDAY MERCK(MRK) THURSDAY

1
Reply
Share
Report
Save
Follow

#MRK🚀🌕

1
Reply
Share
Report
Save
Follow

#XOM CALLS TUESDAY MRK CALLS THURSDAY

1
Reply
Share
Report
Save
Follow

Some implied moves for #earnings next week - 526 companies reporting:
$FB 6.7%
$GOOGL 5.7%
$AMZN 5.6%
$SNAP 17.8%
$PYPL 8.1%
$SBUX 5.1%
$AMD 9.3%
$SPOT 10.7%
$QCOM 8.2%
$ALGN 10.8%
$PENN 11.7%
$REGN 6.8%
$RCL 11.8%
$BIIB 5.1%
$MRK 3.4%
$EL 8.2%
$RL 7.1%
$CHKP 7.0%
$PINS 16.2%
$F 8.3%
$U 13.2%
$SWKS 7.8%
$SKX 10.4%
$FTNT 12.1%
$DECK 11.0%
$WWE 10.1%
$EA 6.4%
$GILD 5.4%
$MTCH 9.4%
$ABBV 3.9%
$RACE 5.6%
$BSX 6.4%
$CPRI 9.8%
$NXPI 7.0%
$UPS 6.5%
$XOM 4.3%
$SMG 9.4%
$SWK 7.7%

1
Reply
Share
Report
Save
Follow

Some implied moves for #earnings next week - 526 companies reporting:

​

$FB 6.7%
$GOOGL 5.7%
$AMZN 5.6%
$SNAP 17.8%
$PYPL 8.1%
$SBUX 5.1%
$AMD 9.3%
$SPOT 10.7%
$QCOM 8.2%
$ALGN 10.8%
$PENN 11.7%
$REGN 6.8%
$RCL 11.8%
$BIIB 5.1%
$MRK 3.4%
$EL 8.2%
$RL 7.1%
$CHKP 7.0%
$PINS 16.2%
$F 8.3%
$U 13.2%
$SWKS 7.8%
$SKX 10.4%
$FTNT 12.1%
$DECK 11.0%
$WWE 10.1%
$EA 6.4%
$GILD 5.4%
$MTCH 9.4%
$ABBV 3.9%
$RACE 5.6%
$BSX 6.4%
$CPRI 9.8%
$NXPI 7.0%
$UPS 6.5%
$XOM 4.3%
$SMG 9.4%
$SWK 7.7%

1
Reply
Share
Report
Save
Follow

Only European companies

IFX 16.22%

ABBN 15.76%

SIE 13.26%

BAYN 13.12%

MRK 11.72%

SAN 11.67%

AMS 9.22%

PHIA 9.05%

1
Reply
Share
Report
Save
Follow

Of course you can pick stocks with more risk than the SP500. But my point is the SPY is not company nor sector nor industry diversified. Big past growers make up way too much space and this is a big risk. A risk that paid good until 2020 but one day will take its price.

If you want to know what stocks I hold here is the list of my divi portfolio (some are spin-offs): ABBV,AVGO,CAT,CLX,CMI,CSCO,CTVA,DD,DOW,EMR,F,FE,GILD,GIS,HST,IBM,IFF,JNJ,K,KD,KMB,LMT,LUMN,MET,MRK,NUE,O,OGN,ONL,OXY,PFE,PFG,PM,PRU,SLB,T,TRI,VTRS,VZ

1
Reply
Share
Report
Save
Follow

I put some of my cash into value mutual funds last week. Bought one LEAP today (MRK January '24) and sold one put (MSFT 240 January '23). Beyond that, I'm trying to sit tight and wait it out.

And I'm trying to not look as often. It's the same superstition I have about my sports teams--they do better if I don't watch.

1
Reply
Share
Report
Save
Follow

This rout definitely caught me off guard and is a good lesson to watch my hedges (I sold SQQQ during the Santa Rally). But I don't really have anything i don't mind holding as I am now heavy in BRK, AAPL, MSFT, MRK.

1
Reply
Share
Report
Save
Follow

Fair. I own JPM, BA, MRK, PRU, AAPL, TSM , ET, BABA, , DIS, PENN, WEBR. Any suggestions on where I went wrong?

1
Reply
Share
Report
Save
Follow

I'll get stoned to death here for saying it, but in this market I would just buy some good dividend/value stocks. SPYD has a pretty good mix. I'm also overweight on MRK.

1
Reply
Share
Report
Save
Follow

Just buy MRK and hold it for, like, ever

1
Reply
Share
Report
Save
Follow

Bottom Feeder Delight -- For what its worth, the "Yahoo Value Rating" just moved MRNA from "Over Priced" to "Fairly Valued" with the drop from $200 to $180s. MRNA is becoming a tasty, technology-rich, takeover target for some old slow Pharma like JNJ, MRK, BMY, or AMGN.

1
Reply
Share
Report
Save
Follow

#MERCK🚀 safest stock to be in right now!! Market down and she’s holding up !! Canada approval coming this week for there pills!! THANK ME LATER!! #MRK

1
Reply
Share
Report
Save
Follow

I noticed someone bought 500x MRK 100c 2/18. Seemed retarded so I bought 50.

1
Reply
Share
Report
Save
Follow

GenX here. I hold T, AAPL, BMY, BTI, XOM, GEF, INTC, MRK, NEM, NRC, SOFI, UL, VZ, V, MAV, SCHY, SCHD, SWISX, and SWSSX.

1
Reply
Share
Report
Save
Follow

100%. I've dialed it in and it's much more of a singles and doubles approach. Also on lower beta stocks like ORCL, WBA, MRK, CVS, etc. And VIX puts when it spikes. I like that "either too rich or too desperate to get rich", nailed it.

1
Reply
Share
Report
Save
Follow
Recent Tweets
$MRK 88% Win rate on 9 closed trades. 3.50 profit factor $8,120 net profit, buy signal in place. Start free trial at https://t.co/6vnULU2sSf https://t.co/90B8FBUQp6
0
0
0
7 of 11 $MCD $MMM $MRK For swing trades the daily timeframe is used. SSI also works well with 30 minutes timeframe for intraday trades and 5 minutes for scalp trades, but you need to install the SSI on your computer for those … see 8/11 https://t.co/pxQtPM1sHZ
0
0
0
$MRK ✈Top analyst price target today.....👌 ✅ https://t.co/u7ecgmYhN0
0
0
0
$mrk Another winning alert based on our custom ThinkorSwim script. 🔗 https://t.co/EjgyTmHgQ3
0
0
0
$NWBO $MRK should definitely look for other immunology alternatives ready 5 years down the road if cheaper. Meanwhile $NWBO can team up with Bristol Meyer Squibs and Optune and wreck Keytruda revenue. https://t.co/yJYPGXA4Iz
0
1
13
$MRK new highs. Low valuation, low volatility, high dividend still a strong part of the market. https://t.co/0aDmGhlRKG
1
3
32
Also, I recently chatted with some folks at $MRK about the newish cardiovascular pipeline. https://t.co/O5y21REER5
0
0
4
$MRK and $NWBO have been very silent. It is difficult to strategize against a silent opponent.
2
3
23
Would $mrk spend $40B on $nwbo to keep and grow $236B? What's survival worth? Keytruda cash cow dashing toward a cliff like a lemming. Better do something fast. LP knows her power over $mrk despite these silly games.
2
3
16
You know who's a fantastic Board member when your scientist are being threatened? CIA Head Cofer Black. $NWBO has had no illusions as to the danger it faced given what's at stake with data this irrefutable, extraordinary, and disruptive. $mrk
0
3
16
$MRK - Merck's blockbuster Keytruda gets EMA panel nod for expanded use in skin cancer https://t.co/SmfbS1AX87
0
1
2
What would $mrk do w/o $nwbo. Patent cliff.
0
0
9
$PDSB hires new business development VP. Got options at $5.35. Has M&A experience. Mayo Clinic just added a mono arm to the PDS-0101 $MRK Keytruda combo trial they are running. Hmm. https://t.co/5nz6Yokrj5
1
2
16
$MRK is probably the best looking chart in the megacaps. $PFE and $NVS aren't terrible either.
3
0
23
$PFE $MRK - Pfizer COVID-19 antiviral use jumps over 300%: U.S. health department https://t.co/DP3q4eFulT
0
1
2
The most beautiful pennant breakout. $MRK https://t.co/Tzp8ftQTzO
1
1
3
After 20 years of absolutely no progress, these healthcare stocks are finally trying to break out of their multi-decade base. $MRK $PFE $BMY https://t.co/NSto0QpSHE
8
55
226
$mrk promoted the relevant endpoints for Keytruda which is now a blockbuster cancer treatment. $nwbo did the same with DCVax-L as the original endpoints became irrelevant. Overall survival is what matters here.
0
4
32
$NWBO Further: Keynote 048 for Pembro (Keytruda) @MERCK https://t.co/Q8VM2nWPMB Overall Survival was PROMOTED FROM SECONDARY TO PRIMARY ENDPOINT following recognition that PFS is a poor surrogate for survival in immunotherapy!!! @AACR geeezzz!!
0
27
109
$MRK Last weeks big winner in big pharma. Try dips off the 8D now if you like it. 21D has been strong support as well https://t.co/wwbXobywyU
0
0
6